环境数据源的景观分析,以与SEER癌症患者数据库进行链接
Zaria Tatalovich1, Amina Chtourou1, Li Zhu1
1Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
Journal of the National Cancer Institute. Monographs
|August 5, 2024
概括
由于历史数据有限,估计癌症患者的终身环境暴露是具有挑战性的. 本研究分析了环境数据来源,以改善癌症监测和研究环境对癌症风险的影响.
科学领域:
- 环境流行病学环境流行病学
- 癌症监测科学 癌症监测科学
- 地理空间健康数据分析.
背景情况:
- 评估癌症患者一生中的环境暴露对于了解癌症风险和结果至关重要.
- 从历史上看,缺乏可靠的预诊断环境暴露测量方法阻碍了此类评估.
- 新兴的时空环境数据和居住历史为将暴露数据纳入癌症监测提供了新的机会.
研究的目的:
- 对环境数据源进行景观分析.
- 识别可与癌症患者的历史住所地址相关联的数据.
- 通过整合环境暴露数据,促进对癌症风险和结果的全面评估.
主要方法:
- 对可用的环境数据源进行景观分析.
- 评估与历史住宅地址信息的链接可行性.
- 审查各种空间和时间尺度的数据收集挑战.
主要成果:
- 确定了潜在的环境数据来源,以便与癌症患者记录进行链接.
- 突出了数据收集,完整性和整合方面的挑战.
- 概述了癌症患者环境暴露评估的未来研究机会.
结论:
- 将各种环境数据源与癌症监测数据相结合是可行的.
- 这种整合可以显著提高对癌症风险和结果的环境影响的评估.
- 需要进一步的研究来解决数据的局限性和优化方法.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Statistical Methods for Analyzing Epidemiological Data
337
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
337
Statistical Software for Data Analysis and Clinical Trials
526
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
526
Comparing the Survival Analysis of Two or More Groups
166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Kaplan-Meier Approach
115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Introduction To Survival Analysis
201
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
201


